Biotech · Private company · Seattle, WA, US
AVM Biotechnology Inc
Track this companyFree. Adds AVM Biotechnology Inc to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- AVM0703Phase 2 · Lymphoid MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- The OPAL Study: AVM0703 for Treatment of Lymphoid MalignanciesPHASE1_PHASE2 · RECRUITING · started Nov 6, 2020ClinicalTrials.gov NCT04329728 · fetched Nov 12, 2026
NIH awards1
- Immunomodulatory AVM0703 to bridge Relapsed/Refractory Diffuse Large B-Cell Lymphoma patients to CAR-T cell immunotherapyFiscal year 2025 · $992.4KNIH RePORTER 1R44CA310370-01 · fetched Nov 12, 2026